SCHEMBL1665742

SCHEMBL1665742

N#CC1=NC=C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1993425 0.47 MAPK1 (0.43)
Water SCHEMBL28254092 0.47 CA2 (0.69)
SCHEMBL45942 0.47 CA2 (0.69)
SCHEMBL60145 0.47 TTR (0.50)
SCHEMBL2503454 0.47 CA2 (0.69)
Water SCHEMBL28189314 0.47 CA2 (0.69)
SCHEMBL57168 0.46 ALDH1A1 (0.47)
Thiocyanic Acid SCHEMBL11417241 0.39 CA1 (0.30)
Thiocyanic Acid SCHEMBL21177322 0.39 TSHR (0.31)
Fluoride Ion SCHEMBL27981128 0.39

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3825278-B1 METHOD FOR PREPARING HIGH-PURITY BISFLUOROSULFONYLIMIDE SALT SHANGHAI ROLECHEM CO LTD (CN) 2025-12-17 EP claimed
EP-3715321-B1 PROCESS FOR THE PREPARATION OF A BISFLUOROSULFONYLIMIDE SALT SHANGHAI ROLECHEM CO LTD (CN) 2025-11-26 EP claimed
EP-4484439-B1 6'-CYANO-MODIFIED LOCKED NUCLEOSIDE, NUCLEOTIDE, AND NUCLEIC ACID POLYMER ACAD OF MILITARY MEDICAL SCIENCES (CN) 2025-09-17 EP claimed
EP-3508478-B1 SALT DERIVATIVE OF TETRAHYDROISOQUINOLINE AND CRYSTALLINE THEREOF AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF CHINA STATE INST PHARM IND (CN) 2022-12-21 EP claimed
WO-2022035115-A1 COMPOSITION FOR PREVENTION AND TREATMENT OF SKELETAL MUSCLE-RELATED DISEASES CONTAINING ALNUS JAPONICA EXTRACT OR COMPOUND ISOLATED THEREFROM AND USE THEREOF 숙명여자대학교 산학협력단 2022-02-17 WO disclosed
US-8765764-B2 2-acylaminothiazole derivative or salt thereof ASTELLAS PHARMA, INC. (JP) 2014-07-01 US disclosed
US-20130079351-A1 2-ACYLAMINOTHIAZOLE DERIVATIVE OR SALT THEREOF ASTELLAS PHARMA, INC. (JP) 2013-03-28 US disclosed
US-8338429-B2 2-acylaminothiazole derivative or salt thereof ASTELLAS PHARMA, INC. (JP) 2012-12-25 US disclosed
EP-2314586-A1 2-Acylaminothiazole derivative or salt thereof Astellas Pharma Inc. (JP) 2011-04-27 EP disclosed
US-20100222329-A1 2-ACYLAMINOTHIAZOLE DERIVATIVE OR SALT THEREOF ASTELLAS PHARMA INC. (JP) 2010-09-02 US disclosed
US-20100222361-A1 2-ACYLAMINOTHIAZOLE DERIVATIVE OR SALT THEREOF ASTELLAS PHARMA INC. (JP) 2010-09-02 US disclosed
US-20070257263-A1 DISPLAY DEVICE KABUSHIKI KAISHA TOSHIBA (JP) 2007-11-08 US disclosed